Interpreting basic tests in Haematology
This is the first of three sessions in the module Haematology in Practice launched on cme30.eu. In this session, Dr David Camilleri, Consultant Haemaologist first discusses the components of the Complete blood Count results and discusses the causes and significance of deviation from the normal…
Management of Common Haematological Conditions
This is the second of three sessions in the module Haematology in Practice launched on cme30.eu. In this session, , Dr David Camilleri, Consultant Haematologist discusses the most common chronic haematological conditions, including criteria for referral of new or known patients with Chronic Lymphatic Leukaemia…
This is the last of three sessions in the module Haematology in Practice launched on cme.eu. In the section on thromboses, Doctor Alexander Gatt, Consultant Haematologist at Mater Dei Hospital, gives us an overview of the risk factors as well as precipitating factors for Deep…
An update in the management of malignant melanoma
An overview of how the management of melanoma has changed in the recent years. We will also discuss the drugs that are currently standard of care in the treatment of melanoma and how these drugs have improved the prognosis of melanoma patients.
Dr. Johann Craus, Obstetrician & Gynaecologist with special interest in pregnancy complicated with Diabetes Mellitus, will be leading this module as part of the The International Masterclass in Diabetes Management. Learning Objectives Diagnosis of GDM is dependent on which diagnostic criteria is used. IADPSG criteria…
Dr. David Coppini, Consultant Diabetologist & Endocrinologist, will be leading this module which will address another important complication of Diabetes Mellitus: diabetic neuropathy. The enigma of neural pain in diabetic individuals , its diagnosis and management will be discussed in detail.
Reducing Cardiovascular Burden in Diabetes – Risk Factor Control
Professor Stephen Fava, Consultant Diabetologist & Endocrinologist, who heads the Diabetes & Endocrine Unit at Mater Dei Hospital, will be discussing risk factor modification in Type 2 Diabetes.
Initiation of insulin in Type 2 Diabetes
This session will provide an overview regarding when and how to inititiate and intensify insulin treatment in type 2 diabetes, the different insulin formulations available, the barriers to insulin therapy, how these best be overcome these and insight into issues in special populations.
Managing Overweight & Obesity in Type 2 diabetes
Managing overweight and obese patients is a challenge each doctor will surely encounter at any point in his practice. Dr. Rachel Agius, Consultant Diabetologist, Endocrinologist, General Physician and Clinical Lead in Bariatric Medicine at Mater Dei Hospital Malta, provides us with the most updated knowledge…